CRDL
Price
$1.54
Change
+$0.15 (+10.79%)
Updated
Jul 3 closing price
Capitalization
124.33M
43 days until earnings call
ELAN
Price
$14.64
Change
-$0.08 (-0.54%)
Updated
Jul 3 closing price
Capitalization
7.87B
36 days until earnings call
Interact to see
Advertisement

CRDL vs ELAN

Header iconCRDL vs ELAN Comparison
Open Charts CRDL vs ELANBanner chart's image
Cardiol Therapeutics
Price$1.54
Change+$0.15 (+10.79%)
Volume$368.42K
Capitalization124.33M
Elanco Animal Health
Price$14.64
Change-$0.08 (-0.54%)
Volume$2.01M
Capitalization7.87B
CRDL vs ELAN Comparison Chart in %
Loading...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDL vs. ELAN commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDL is a Hold and ELAN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CRDL: $1.54 vs. ELAN: $14.64)
Brand notoriety: CRDL: Not notable vs. ELAN: Notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRDL: 191% vs. ELAN: 33%
Market capitalization -- CRDL: $124.33M vs. ELAN: $7.87B
CRDL [@Pharmaceuticals: Other] is valued at $124.33M. ELAN’s [@Pharmaceuticals: Other] market capitalization is $7.87B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDL’s FA Score shows that 0 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).

  • CRDL’s FA Score: 0 green, 5 red.
  • ELAN’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRDL and ELAN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDL’s TA Score shows that 3 TA indicator(s) are bullish while ELAN’s TA Score has 5 bullish TA indicator(s).

  • CRDL’s TA Score: 3 bullish, 5 bearish.
  • ELAN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ELAN is a better buy in the short-term than CRDL.

Price Growth

CRDL (@Pharmaceuticals: Other) experienced а +4.76% price change this week, while ELAN (@Pharmaceuticals: Other) price change was +2.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.02%. For the same industry, the average monthly price growth was +2.94%, and the average quarterly price growth was +92.60%.

Reported Earning Dates

CRDL is expected to report earnings on Aug 18, 2025.

ELAN is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.02% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than CRDL($124M). ELAN (20.892) and CRDL (20.313) have similar YTD gains . CRDL has higher annual earnings (EBITDA): -30.61M vs. ELAN (-224M). ELAN has more cash in the bank: 352M vs. CRDL (40.5M). CRDL has less debt than ELAN: CRDL (181K) vs ELAN (5.77B). ELAN has higher revenues than CRDL: ELAN (4.42B) vs CRDL (0).
CRDLELANCRDL / ELAN
Capitalization124M7.87B2%
EBITDA-30.61M-224M14%
Gain YTD20.31320.89297%
P/E RatioN/AN/A-
Revenue04.42B-
Total Cash40.5M352M12%
Total Debt181K5.77B0%
FUNDAMENTALS RATINGS
CRDL vs ELAN: Fundamental Ratings
CRDL
ELAN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9981
PRICE GROWTH RATING
1..100
3941
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELAN's Valuation (92) in the Agricultural Commodities Or Milling industry is in the same range as CRDL (97) in the null industry. This means that ELAN’s stock grew similarly to CRDL’s over the last 12 months.

ELAN's Profit vs Risk Rating (100) in the Agricultural Commodities Or Milling industry is in the same range as CRDL (100) in the null industry. This means that ELAN’s stock grew similarly to CRDL’s over the last 12 months.

ELAN's SMR Rating (81) in the Agricultural Commodities Or Milling industry is in the same range as CRDL (99) in the null industry. This means that ELAN’s stock grew similarly to CRDL’s over the last 12 months.

CRDL's Price Growth Rating (39) in the null industry is in the same range as ELAN (41) in the Agricultural Commodities Or Milling industry. This means that CRDL’s stock grew similarly to ELAN’s over the last 12 months.

ELAN's P/E Growth Rating (93) in the Agricultural Commodities Or Milling industry is in the same range as CRDL (100) in the null industry. This means that ELAN’s stock grew similarly to CRDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDLELAN
RSI
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
53%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
59%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
64%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 5 days ago
62%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SQEW33.710.13
+0.38%
LeaderShares® Equity Skew ETF
BILD26.91N/A
N/A
Macquarie Global Listed Infras ETF
LQPE18.58N/A
N/A
PEO AlphaQuest Thematic PE ETF
SH39.25-0.28
-0.71%
ProShares Short S&P500
QID24.93-0.47
-1.85%
ProShares UltraShort QQQ

CRDL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDL has been loosely correlated with SCYX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDL jumps, then SCYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
+10.79%
SCYX - CRDL
34%
Loosely correlated
+1.57%
AQST - CRDL
34%
Loosely correlated
+1.09%
TLRY - CRDL
30%
Poorly correlated
+11.03%
ACB - CRDL
30%
Poorly correlated
+1.57%
ELAN - CRDL
29%
Poorly correlated
-0.54%
More

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with ZTS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
-0.54%
ZTS - ELAN
48%
Loosely correlated
+0.06%
VTRS - ELAN
46%
Loosely correlated
-0.21%
PAHC - ELAN
40%
Loosely correlated
+0.21%
AMRX - ELAN
33%
Loosely correlated
+0.60%
OGI - ELAN
33%
Poorly correlated
+3.62%
More